Changing Faces of Clinical Tuberculosis

  • William W. Stead
  • Asim K. Dutt
Part of the Infectious Agents and Pathogenesis book series (IAPA)


Throughout recorded and archeologic history, tuberculosis has affected humans in every part of the world. Even today, tuberculosis is a major cause of morbidity and mortality in many countries, despite extensive understanding of its cause, epidemiology, prevention, and therapy.1 There has been considerable change in the face of the disease, with a shift from the young and female to the old and male.2 In densely populated developing countries, it remains a major killer of the young.


Nursing Home Health Care Worker Pulmonary Tuberculosis Preventive Therapy Archeologic History 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kass, E. H., 1971, Infectious diseases and social changes, J. Infect. Dis. 123:100–14.CrossRefGoogle Scholar
  2. 2.
    Anonymous, 1986, Tuberculosis-United States 1985, MMWR 35:699–703.Google Scholar
  3. 3.
    Anonymous, 1986, Tuberculosis-United States 1985-and the possible impact of Human T-Lymphotropic versus Type III/lymphodenopathy-associated virus infection, MMWR 35(5):74–76.Google Scholar
  4. 4.
    Anonymous, 1986, Prognosis and management of Mycobacterial infection and disease in persons with Human T-Lymphotropic versus Type III/Lymphadenopathy-associ-ated virus infection, MMWR 35:448–452.Google Scholar
  5. 5.
    Anonymous, 1986, Case records of the Massachusetts General Hospital, N. Engl. J. Med. 314: 167–174.CrossRefGoogle Scholar
  6. 6.
    Nardell, E., Mclnnis, B., Thomas, B., and Weidhass, S., 1986, Exogenous reinfection with tuberculosis in a shelter for the homeless, N. Engl. J. Med. 315:1570–1575.PubMedCrossRefGoogle Scholar
  7. 7.
    Stead, W. W., and Lofgren, J. P., 1983, Does the risk of tuberculosis increase in old age?, J. Infect. Dis. 147:951–955.PubMedCrossRefGoogle Scholar
  8. 8.
    Anonymous, 1985, Drug resistant tuberculosis among the homeless-Boston, MMWR 34:429–431.Google Scholar
  9. 9.
    Patel, K. R., 1985, Pulmonary tuberculosis in residents of lodging houses, night shelters, and common hostels in Glasgow: A 5-year prospective study, Br. J. Dis. Chest 79:60–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Stead, W. W., Lofgren, J. P., Warren, E., and Thomas, C., 1985, Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes, N. Engl. J. Med. 312:1483–1487.PubMedCrossRefGoogle Scholar
  11. 11.
    Greenbaum, M. B., Beyt, B. E., and Murray, P. R., 1980, The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital, Am. Rev. Respir. Dis. 121:477–481.PubMedGoogle Scholar
  12. 12.
    Khan, M. A., Kovnat, D. M., Bachus, B., Whitcomb, M. E., Brody, J. S., and Snider, G. L., 1977, Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adults, Am. J. Med. 62:31–38.PubMedCrossRefGoogle Scholar
  13. 13.
    Farman, D. P., and Speir, W. A., 1986, Initial roentgenographic manifestations of bacteriologically proven Mycobacterium tuberculosis: Typical or atypical? Chest 89:75– 77.PubMedCrossRefGoogle Scholar
  14. 14.
    Bloch, A. B., Snider, D. E., Jr., 1986, How much tuberculosis in children must we accept?, Am. J. Public Health 76:14–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Millar, J. W., and Home, N. W., 1979, Tuberculosis in immunosuppressed patients, Lancet 1:1176–1178.PubMedCrossRefGoogle Scholar
  16. 16.
    Pitchenik, A. E., Cole, C., Russell, B. W., Fischl, M. A., Spira, T. J., and Snider, D. E., Jr., 1984, Tuberculosis, atypical mycobacterosis and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida, Ann. Intern. Med. 101:641–645.PubMedGoogle Scholar
  17. 17.
    Sunderam, G., McDonald, R. J., Maniatis, T., Oleska, J., Kapila, R., and Reichman, L. B., 1986, Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS), JAMA 256:362–366.PubMedCrossRefGoogle Scholar
  18. 18.
    Geiseler, P. J., Nelson, K. E., Crispen, R. G., and Moses, V. K., 1986, Tuberculosis in physicians: A continuing problem, Am. Rev. Respir. Dis. 133:773–778.PubMedGoogle Scholar
  19. 19.
    Geiseler, P. J., Nelson, K. E., and Crispen, R. G., 1987, Tuberculosis in physicians: Compliance with preventive measures, Am. Rev. Respir. Dis. 135:3–9.PubMedGoogle Scholar
  20. 20.
    Miller, B., and Snider, D. E.,Jr., 1987, Physicians noncompliance with tuberculosis preventive measures. Am. Rev. Respir. Dis. 135:1–2.PubMedGoogle Scholar
  21. 21.
    International Union Against Tuberculosis Committee on prophylaxis, 1982, Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow up in the IUAT trial, Bull WHO 60:555–564.Google Scholar
  22. 22.
    Snider, D. E., and Farer, L. S., 1984, Preventive therapy for tuberculosis infection: An intervention in need of improvement, Am. Rev. Respir. Dis. 130:355–356.PubMedGoogle Scholar
  23. 23.
    Stead, W. W., 1981, Tuberculosis among elderly persons: An outbreak in a nursing home, Ann. Intern. Med. 94:606–610.PubMedGoogle Scholar
  24. 24.
    Grosset, J., 1980, Bacteriologic basis for short course chemotherapy for tuberculosis, Clin. Chest Med. 1:231–241.PubMedGoogle Scholar
  25. 25.
    Fox, W., 1981, Whither short course chemotherapy?, Br. J. Dis. Chest 75:331–357.PubMedCrossRefGoogle Scholar
  26. 26.
    Dutt, A. K., Moers, D., and Stead, W. W.. 1984, Short course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin: Community physicians with mainly outpatients, Am. J. Med. 77:233–242.PubMedCrossRefGoogle Scholar
  27. 27.
    Singapore Tuberculosis Source/British Medical Research Council, 1986, Long-term follow-up of a clinical trial of six month and four month regimens of chemotherapy in the treatment of pulmonary tuberculosis, Am. Rev. Respir. Dis. 133:779–783.Google Scholar
  28. 28.
    American Thoracic Society, 1986, Treatment of tuberculosis and tuberculosis infection in adults and children, Am. Rev. Respir. Dis. 134:355–363.Google Scholar
  29. 29.
    Dutt, A. K., Moers, D., and Stead, W. W., 1986, Short course chemotherapy for extrapulmonary tuberculosis: Nine years experience, Ann. Intern. Med. 104:7–12.PubMedGoogle Scholar
  30. 30.
    Girling, D. J., 1978, The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampin and pyrazinamide, Tubercle 59: 13–32.CrossRefGoogle Scholar
  31. 31.
    Dutt, A. K., Moers, D., and Stead, W. W., 1983, Undesirable side effects of isoniazid and rifampin in largely twice-weekly short course chemotherapy for tuberculosis, Am. Rev. Respir. Dis. 128:419–424.PubMedGoogle Scholar
  32. 32.
    Stead, W. W., and To, T., 1987, The significance of the tuberculin test in elderly persons, Ann. Int. Med. 107:837–842.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • William W. Stead
    • 1
    • 2
  • Asim K. Dutt
    • 3
    • 4
  1. 1.University of Arkansas for Medical SciencesUSA
  2. 2.Tuberculosis ProgramArkansas Department of HealthLittle RockUSA
  3. 3.Alvin C. York Veterans Administration Medical CenterMurfreesboroUSA
  4. 4.Department of MedicineMeharry Medical CollegeNashvilleUSA

Personalised recommendations